149 related articles for article (PubMed ID: 30297384)
1. Clinical Benefit to an Aurora A Kinase Inhibitor in a Patient with Metastatic Integrase Interactor 1-Deficient Carcinoma.
Karantanos T; Rooper L; Kang Y; Lin CT; Wenga P; Sagorsky S; Lauring J; Kang H
Oncologist; 2019 Feb; 24(2):146-150. PubMed ID: 30297384
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)-Deficient Carcinomas of the Urinary System.
Gupta S; Albertson D; Gaston D; Heilbrun ME; Agarwal N; Boucher K; Parnell TJ; Liu T; Morgans A; Madison R; Gowen K; Miller VA; Ross JS; Ali SM; Millis SZ
Clin Genitourin Cancer; 2018 Apr; 16(2):e373-e382. PubMed ID: 28974397
[TBL] [Abstract][Full Text] [Related]
3. Integrase Interactor 1 (INI-1) Deficient Renal Cell Carcinoma.
Singh M; Singh H; Hambro B; Kaur J; Rao R
Cureus; 2021 Feb; 13(2):e13082. PubMed ID: 33680622
[TBL] [Abstract][Full Text] [Related]
4. INI-1 (SMARCB1)-Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal Malignancies.
Shaverdashvili K; Azimi-Nekoo E; Cohen P; Akbar N; Ow TJ; Halmos B; Castellucci E
Oncologist; 2020 Sep; 25(9):738-744. PubMed ID: 32337786
[TBL] [Abstract][Full Text] [Related]
5. Cytopathologic features of SMARCB1 (INI-1)-deficient sinonasal carcinoma.
Allard FD; Bell D; Stelow EB
Cancer Cytopathol; 2018 Aug; 126(8):567-574. PubMed ID: 29797680
[TBL] [Abstract][Full Text] [Related]
6. Metastatic SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Fine-Needle Aspiration (EBUS-FNA): A Potential Diagnostic Pitfall and Review of the Literature.
McHugh KE; Policarpio-Nicolas MLC
Acta Cytol; 2019; 63(5):431-437. PubMed ID: 31132763
[TBL] [Abstract][Full Text] [Related]
7. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
[TBL] [Abstract][Full Text] [Related]
8. Cytopathologic characteristics of SMARCB1 (INI-1) deficient sinonasal carcinoma: A potential diagnostic pitfall.
Allison DB; Bishop JA; Ali SZ
Diagn Cytopathol; 2016 Aug; 44(8):700-3. PubMed ID: 27177850
[TBL] [Abstract][Full Text] [Related]
9. Beware of the sneeze.
Yang P; Toomey CB; Lin J; Kikkawa DO; Korn BS; Harrison A
Surv Ophthalmol; 2020; 65(5):592-596. PubMed ID: 30978335
[TBL] [Abstract][Full Text] [Related]
10. SMARCB1-deficient carcinomas of the head and neck region: a cytopathologic characterization.
Kezlarian BE; Lin O; Dogan S
J Am Soc Cytopathol; 2020; 9(6):494-501. PubMed ID: 32839151
[TBL] [Abstract][Full Text] [Related]
11. Vulvar Yolk Sac Tumors Are Somatically Derived SMARCB1 (INI-1)-Deficient Neoplasms.
Kolin DL; Konstantinopoulos PA; Campos SM; Toumi G; Kolahi KA; Gars EJ; Howitt BE
Am J Surg Pathol; 2022 Feb; 46(2):169-178. PubMed ID: 34265804
[TBL] [Abstract][Full Text] [Related]
12. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
Pawel BR
Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
[TBL] [Abstract][Full Text] [Related]
13. SMARCB1 (INI-1) - Deficient sinonasal carcinoma: Report of two cases.
Vasudevan G; Srinivas SP; Nayal B; Jayaprakash P; Ramaswamy B
Indian J Pathol Microbiol; 2023; 66(2):352-355. PubMed ID: 37077082
[TBL] [Abstract][Full Text] [Related]
14. SMARCB1(INI-1)-Deficient Sinonasal Carcinoma: An Evolving Entity.
Chung SY; Kenee P; Mitton T; Halderman A
J Neurol Surg Rep; 2023 Jan; 84(1):e1-e5. PubMed ID: 36712411
[TBL] [Abstract][Full Text] [Related]
15. Reappraisal of SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1/INI-1 deficient tumor: Report of two cases.
Gurung N; Kapoor N; Mukherjee U; Khurana A
J Cancer Res Ther; 2022; 18(3):780-783. PubMed ID: 35900556
[TBL] [Abstract][Full Text] [Related]
16. SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma: A Case Report and Literature Review.
Yang H; Zhou L; Zhong G; Li X; Wang Y
Ear Nose Throat J; 2022 May; ():1455613221082622. PubMed ID: 35603532
[No Abstract] [Full Text] [Related]
17. SMARCB1/INI1 Is Diagnostically Useful in Distinguishing α-Fetoprotein-producing Gastric Carcinoma from Hepatocellular Carcinoma.
Mochizuki K; Kawai M; Odate T; Tahara I; Inoue T; Kasai K; Nakazawa T; Kondo T
Anticancer Res; 2018 Dec; 38(12):6865-6868. PubMed ID: 30504402
[TBL] [Abstract][Full Text] [Related]
18. SMARCB1 (INI-1) and NUT immunoexpression in a large series of head and neck carcinomas in a Brazilian reference center.
Neves-Silva R; Almeida LY; Silveira HA; Colturato CBN; Duarte A; Ferrisse TM; Silva EV; Vanzolin BF; Bufalino A; Ribeiro-Silva A; León JE
Head Neck; 2020 Mar; 42(3):374-384. PubMed ID: 31729110
[TBL] [Abstract][Full Text] [Related]
19. Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer.
Oike T; Ogiwara H; Nakano T; Yokota J; Kohno T
Jpn J Clin Oncol; 2013 Sep; 43(9):849-55. PubMed ID: 23904343
[TBL] [Abstract][Full Text] [Related]
20. An Adrenal SMARCB1/INI1 Deficient Proximal Epithelioid Sarcoma in a Middle-Aged Female: A Case Report.
Brodie Z; McCartney E; Toledo S
Cureus; 2022 Sep; 14(9):e29242. PubMed ID: 36262954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
